Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world’s largest vaccine manufacturer by volume, today announced that the National Agency of Drug and Food Control of the Republic of Indonesia, or Badan Peng was Obat dan Makanan […]

thaipr.net

2 พ.ย. 64

China’s New Regulation on Internet Healthcare will Benefit Platforms like WeDoctor

On 27 October, China’s National Health Commission (NHC), the authority responsible for the medical industry, issued a new policy that calls for the regulation of China’s fast-growing Internet healthcare industry. The policy is expected to push China’s internet healthcare industry into the era of standardized development. According to the NHC, as of June 2021, the […]

thaipr.net

1 พ.ย. 64

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom

Filing marks first protein-based COVID-19 vaccine submitted to MHRA for authorization All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high efficacy and well-tolerated safety, including against variants Submissions to additional global regulatory authorities including EU, Canada and Australia expected soon Novavax, Inc. […]

thaipr.net

28 ต.ค. 64

Abcam completes $340m strategic acquisition and expands kit capacity and capability

– Completing $340m strategic acquisition of BioVision – Expanding facilities in Eugene, further growing kits and assays portfolio – Supporting the growing demand of the sector and accelerating execution of strategic plan Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expansion of its immunoassay […]

thaipr.net

27 ต.ค. 64

Medigen’s MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv). Following the review of around 20 candidate vaccines by the external advisory group, MVC’s vaccine was selected as one of two to be included in the global […]

thaipr.net

27 ต.ค. 64
1 91 92 93 94 95 128